Dr. Sharon Glynn is a molecular epidemiologist and basic scientist with an interest in hormone independent prostate and breast cancer. She is currently the Director of Laboratory Research at the Prostate Cancer Institute at the National University of Ireland (NUI) Galway, and co-coordinator of the MSC in Cancer Research at NUI Galway. Dr. Glynn holds a BSc (1997) and a PhD (2003) in Biotechnology from Dublin City University (DCU). She also holds a Master in Public Health (2006) from University College Dublin. Dr. Glynn worked as a research officer in the National Institute for Cellular Biotechnology in DCU (2003-2005), before joining the National Cancer Institute’s Cancer Prevention Fellowship Program (CPFP) in Bethesda, Maryland, USA (2005-2009) as an All-Ireland-NCI Cancer Consortium Scholar. She spent a year in the Radiation Biology Branch at the NCI as a Visiting Fellow, before returning to Ireland in September 2010 to take up her current post. Dr. Glynn’s specific research interests are the interrelation of iNOS and COX2 signalling in hormone independent prostate and breast cancer, prostate cancer brachytherapy radiogenomics, and human endogenous retrovirus activation in prostate and breast cancer.